Los Angeles Business Journal

Onyx Rebuffs Amgen's Offer

Monday, July 1, 2013

Onyx Pharmaceuticals Inc., maker of the cancer drug Nexavar, said it is seeking potential buyers after rejecting an unsolicited acquisition offer from Amgen Inc. of about $8.7 billion, The Wall Street Journal reports.